Latest News
Featured News
Q&A with Scancell CMO Nermeen Varawalla
Could you tell us a bit about your background and what attracted you to Scancell? Given my educational background, which includes an MD in clinical medicine, DPhil (Oxon) in molecular medicine and INSEAD MBA, along with extensive leadership and clinical development...
Select the category
Modi-1 trial open for expansion in combination with checkpoint inhibitors
Extension of exercise period for CEO share options
Pipeline strategy and business update
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting
Issue of share options to Non-Executive Directors
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.